Botanical species · safety record

Haplophyllum perforatum

The EFSA Compendium of Botanicals holds 13 constituent measurements for Haplophyllum perforatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Haplophyllum perforatum (M. Bieb.) Vved.

13Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Also recorded as

Haplophyllum acutifolium (DC.) G.Don

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Flower	Essential oil	22.8 Percent	Gaschromatography (GC)	Resolve DOI
Alkaloids	Aerial part of plants	—	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Camphor	Flower	Essential oil	19.9 Percent	Gaschromatography (GC)	Resolve DOI
Haplamine	Leaves	Solvent extraction	≤ 5.24 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Haplamine	Leaves	Solvent extraction	≥ 1.23 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Haplopine	Leaves	Solvent extraction	≥ 0.43 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Haplopine	Leaves	Solvent extraction	≤ 0.8 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Myrcene	Leaves	Essential oil	1 Percent	Gaschromatography (GC)	Resolve DOI
Skimmianine	Leaves	Solvent extraction	≤ 2.75 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Skimmianine	Leaves	Solvent extraction	≥ 0.1 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Alkaloids	Unspecified	—	—	Unspecified	No resolvable identifier
Coumarins	Unspecified	—	—	Unspecified	No resolvable identifier
Coumarins	Unspecified	—	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Fiot, Julien., Jansen, Olivia., Akhmedjanova, Valentina., Angenot, Luc., Balansard, Guy., Ollivier, Evelyne. HPLC quantification of alkaloids from Haplophyllum extracts and comparison with their cytotoxic properties . Phytochemical analysis, 2006, vol. 17, no. 5, p. 365-369. DOI
Aminov, S. D., Vakhabov, A. A. Pharmacology of some coumarins isolated from the plant Haplophyllum. Doklady akademii nauk uzssr, 1985, p. 44-45.
Mohammadhosseini, Majid., Nekoei, Mehdi., Mashayekhi, Hossein Ali., Aboli, Jafar. Chemical Composition of the Essential Oil from Flowers, Leaves and Stems of Haplophyllum perforatum by Using Head Space Solid Phase Microextraction . Journal of essential oil bearing plants, 2012, vol. 15, no. 4, p. 506-515. DOI
Jansen, O., Akhmedjanova, V., Angenot, L., Balansard, G., Chariot, A., Ollivier, E., Tits, M., Frederich, M. Screening of 14 alkaloids isolated from Haplophyllum A. Juss. for their cytotoxic properties . Journal of ethnopharmacology, 2006, vol. 105, no. 1-2, p. 241-245. DOI
Polievtsev, N. P., Kamilov, I. K. Pharmacology of the alkaloid, haploperin (eudoxin). Farmakol. alk. (tashkent: nauka), 1965, p. 14-22.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature